AI assistant
Cabaletta Bio, Inc. — Director's Dealing 2022
Oct 19, 2022
33628_dirs_2022-10-18_035ec7d5-a8f7-4f3c-9995-00f9416f1c33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2022-10-18
Reporting Person: Nichtberger Steven (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-10-18 | Common Stock | P | 141873 | $0.9939 | Acquired | 978356 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 363000 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9473 to $1.00, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.